Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: littlebitmoore2 who wrote (2521)	6/17/2009 12:15:48 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

OPK, the Miami company headed by Dr. Phillip Frost, has a large LTD,but earlier this month it raised $31M in private placement transactions, with the issue of 31M restricted shares of common at $1.00 per share, and the company has not been loosing any time in putting that cash to work. <g> On Jun 11, it announced an investment in Sorrento Therapeutics of San Diego, which has a platform technology for the generation of fully human monoclonal antibodies.OPK acquired 1/3 of the outstanding shares of Sorrento and received an exclusive license to the Sorrento antibody library for the discovery and development of therapeutic antibodies in the ophthalmology field. Yesterday it announced that it was making an investment in Cocrystal Discovery a biopharmaceutical Co. focusing initially on the discovery and development of antiviral drugs, with the first targets viruses that cause the common cold and hepatitis C. And today it announced that it has acquired exclusive rights to a technology developed at the Univ. of TX Southwestern Med. Cntr., by Thomas Kodadek, Ph.D., and his team. Dr. Kodadek, had recently joined the faculty at Scripps in Jupiter, FL. The new platform technology is for the rapid identification of molecules that can be useful as vaccines and new drugs, and to create new diagnostic tests. The stock was able to trade earlier this month,(before the recent market slump.<g>), above its Jan. H. bigcharts.marketwatch.com The stock is starting to get off from the DT coming from its early 2007 H above the $5 level.<g> bigcharts.marketwatch.com Bernard

To: littlebitmoore2 who wrote (2521)	6/24/2009 2:16:35 PM
From: Jibacoa	Respond to of 3722

That was a good move on your part.<g> TPI expects to report its 4thQ (June) revenues of $42M and earnings of at least $7.5M. (About 25% and 26% growth respectively.) For 2010 its 'guidance' is $59M in revenues & $10.5M in earnings. (About 40% and 42% growth over estimated fiscal 2009.) On Monday it announced that it is set to join the Russell Microcap Index on June 26. The stock is trying to bounce from today's L, but it is still down 1.64% for the day with volume already ahead of its ADV. The stock had a good % gain from its $1 level in March to its June 15 H at the $3.50 level. Will see if it can hold at the support of $2.20 without testing the more important one at $2.<g> bigcharts.marketwatch.com The forward PE is <5 and the 'insiders' reportedly hold close to 80% of the shares.<g> It has positive CF but negative FCF.<g> finance.yahoo.com Bernard